Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 3 |
2019 | 1 |
2020 | 3 |
2021 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8.
N Engl J Med. 2015.
PMID: 26052984
Free article.
Clinical Trial.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK; VERTIS CV Investigators.
Cannon CP, et al.
N Engl J Med. 2020 Oct 8;383(15):1425-1435. doi: 10.1056/NEJMoa2004967. Epub 2020 Sep 23.
N Engl J Med. 2020.
PMID: 32966714
Clinical Trial.
Item in Clipboard
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators.
Pfeffer MA, et al.
N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225.
N Engl J Med. 2015.
PMID: 26630143
Free article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators.
Pieber TR, et al.
Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9.
Lancet Diabetes Endocrinol. 2019.
PMID: 31189520
Clinical Trial.
Item in Clipboard
The triad macrosomia, obesity, and hypertriglyceridemia in gestational diabetes.
Gorban de Lapertosa S, Alvariñas J, Elgart JF, Salzberg S, Gagliardino JJ; EduGest group.
Gorban de Lapertosa S, et al.
Diabetes Metab Res Rev. 2020 Jul;36(5):e3302. doi: 10.1002/dmrr.3302. Epub 2020 Mar 5.
Diabetes Metab Res Rev. 2020.
PMID: 32068345
Item in Clipboard
Prevalence of gestational diabetes mellitus in Argentina according to the Latin American Diabetes Association (ALAD) and International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria and the associated maternal-neonatal complications.
Gorban de Lapertosa S, Sucani S, Salzberg S, Alvariñas J, Faingold C, Jawerbaum A, Rovira G; DPSG-SAD Group.
Gorban de Lapertosa S, et al.
Health Care Women Int. 2021;42(4-6):636-656. doi: 10.1080/07399332.2020.1800012. Epub 2020 Sep 4.
Health Care Women Int. 2021.
PMID: 32886577
Item in Clipboard
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, Solomon SD, Tardif JC, Wu Y, Pfeffer MA; ELIXA Investigators.
Bentley-Lewis R, et al.
Am Heart J. 2015 May;169(5):631-638.e7. doi: 10.1016/j.ahj.2015.02.002. Epub 2015 Feb 12.
Am Heart J. 2015.
PMID: 25965710
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite